2013 Q1 Form 10-Q Financial Statement

#000070738813000014 Filed on May 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q3 2012 Q1
Revenue $11.55M $11.82M $12.97M
YoY Change -10.97% -12.07% -8.51%
Cost Of Revenue $8.729M $8.688M $9.297M
YoY Change -6.11% -6.47% -12.75%
Gross Profit $2.817M $3.129M $3.672M
YoY Change -23.28% -24.6% 4.35%
Gross Profit Margin 24.4% 26.48% 28.31%
Selling, General & Admin $3.338M $3.092M $3.980M
YoY Change -16.13% -9.67% 12.81%
% of Gross Profit 118.49% 98.82% 108.39%
Research & Development $818.0K $1.055M $897.0K
YoY Change -8.81% 50.28% 26.69%
% of Gross Profit 29.04% 33.72% 24.43%
Depreciation & Amortization $493.0K $524.0K $579.0K
YoY Change -14.85% -15.76% -32.83%
% of Gross Profit 17.5% 16.75% 15.77%
Operating Expenses $5.226M $4.196M $4.954M
YoY Change 5.49% -0.14% 18.92%
Operating Profit -$2.409M -$1.067M -$1.282M
YoY Change 87.91% 1951.92% 98.15%
Interest Expense $0.00 $2.000K $0.00
YoY Change -98.18% -100.0%
% of Operating Profit
Other Income/Expense, Net $22.00K $26.00K $14.00K
YoY Change 57.14% -82.78% -94.62%
Pretax Income -$2.387M -$1.041M -$1.270M
YoY Change 87.95% -1141.0% 225.64%
Income Tax $32.00K -$135.0K $0.00
% Of Pretax Income
Net Earnings -$2.419M -$906.0K -$1.268M
YoY Change 90.77% -1015.15% 227.65%
Net Earnings / Revenue -20.95% -7.67% -9.78%
Basic Earnings Per Share -$0.13 -$0.05
Diluted Earnings Per Share -$0.13 -$0.05 -$661.5K
COMMON SHARES
Basic Shares Outstanding 19.32M shares 19.26M shares 19.24M shares
Diluted Shares Outstanding 19.32M shares 19.26M shares 19.24M shares

Balance Sheet

Concept 2013 Q1 2012 Q3 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.80M $27.20M $29.10M
YoY Change -11.34% -13.92% -4.9%
Cash & Equivalents $15.54M $18.34M $23.79M
Short-Term Investments $10.20M $8.800M $5.300M
Other Short-Term Assets $792.0K $722.0K $956.0K
YoY Change -17.15% -27.8% -31.71%
Inventory $4.868M $6.573M $6.068M
Prepaid Expenses
Receivables $5.818M $6.864M $7.167M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $37.49M $41.57M $43.50M
YoY Change -13.82% -8.83% -4.82%
LONG-TERM ASSETS
Property, Plant & Equipment $4.557M $5.148M $5.115M
YoY Change -10.91% -11.24% -20.08%
Goodwill $184.0K $184.0K $184.0K
YoY Change 0.0%
Intangibles $518.0K $293.0K $399.0K
YoY Change 29.82%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.259M $5.625M $5.698M
YoY Change -7.7% -14.77% -21.95%
TOTAL ASSETS
Total Short-Term Assets $37.49M $41.57M $43.50M
Total Long-Term Assets $5.259M $5.625M $5.698M
Total Assets $42.74M $47.20M $49.20M
YoY Change -13.11% -9.58% -7.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.898M $1.906M $1.784M
YoY Change 6.39% 12.12% -25.67%
Accrued Expenses $2.900M $5.200M $5.000M
YoY Change -42.0% 10.64% 6.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.368M $8.879M $8.748M
YoY Change -4.34% 8.28% -4.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $257.0K $200.0K $100.0K
YoY Change 157.0% 100.0% 0.0%
Total Long-Term Liabilities $257.0K $200.0K $100.0K
YoY Change 157.0% 100.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.368M $8.879M $8.748M
Total Long-Term Liabilities $257.0K $200.0K $100.0K
Total Liabilities $8.625M $9.043M $8.869M
YoY Change -2.75% 7.65% -5.65%
SHAREHOLDERS EQUITY
Retained Earnings -$120.5M -$116.3M -$114.5M
YoY Change 5.31%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.106M $2.087M $1.178M
YoY Change 78.78%
Treasury Stock Shares 1.082M shares 643.7K shares
Shareholders Equity $34.12M $38.15M $40.33M
YoY Change
Total Liabilities & Shareholders Equity $42.74M $47.20M $49.20M
YoY Change -13.11% -9.58% -7.18%

Cashflow Statement

Concept 2013 Q1 2012 Q3 2012 Q1
OPERATING ACTIVITIES
Net Income -$2.419M -$906.0K -$1.268M
YoY Change 90.77% -1015.15% 227.65%
Depreciation, Depletion And Amortization $493.0K $524.0K $579.0K
YoY Change -14.85% -15.76% -32.83%
Cash From Operating Activities -$1.169M -$480.0K -$1.065M
YoY Change 9.77% -172.73% -297.96%
INVESTING ACTIVITIES
Capital Expenditures $189.0K -$480.0K $187.0K
YoY Change 1.07% 152.63% 81.55%
Acquisitions $0.00
YoY Change
Other Investing Activities -$2.630M $660.0K $1.080M
YoY Change -343.52% 100.0% 44.0%
Cash From Investing Activities -$2.818M $180.0K $896.0K
YoY Change -414.51% 28.57% 38.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$9.000K $84.00K
YoY Change -110.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.000K -390.0K -$84.00K
YoY Change -110.71% -533.33% 44.83%
NET CHANGE
Cash From Operating Activities -$1.169M -480.0K -$1.065M
Cash From Investing Activities -$2.818M 180.0K $896.0K
Cash From Financing Activities $9.000K -390.0K -$84.00K
Net Change In Cash -$3.978M -690.0K -$253.0K
YoY Change 1472.33% -177.53% -122.45%
FREE CASH FLOW
Cash From Operating Activities -$1.169M -$480.0K -$1.065M
Capital Expenditures $189.0K -$480.0K $187.0K
Free Cash Flow -$1.358M $0.00 -$1.252M
YoY Change 8.47% -100.0% -387.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1546000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1898000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6329000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5818000 USD
CY2012Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-30000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156634000 USD
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156783000 USD
CY2013Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-46000 USD
CY2013Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
650000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-21301000 USD
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-21616000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
319000 shares
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
495000 shares
CY2012Q4 us-gaap Assets
Assets
44909000 USD
CY2013Q1 us-gaap Assets
Assets
42744000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
39448000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
37485000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
7679000 USD
CY2013Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
10227000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15536000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19514000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23786000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24039000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-253000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3978000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19277171 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19144448 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19144448 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2459000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1265000 USD
CY2012Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9297000 USD
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8729000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1904000 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2321000 USD
CY2012Q1 us-gaap Cost Of Services
CostOfServices
6976000 USD
CY2013Q1 us-gaap Cost Of Services
CostOfServices
6825000 USD
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1480000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1849000 USD
CY2012Q1 us-gaap Depreciation
Depreciation
502000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
427000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
579000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
493000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2364000 USD
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2616000 USD
CY2012Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
17000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2265000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2102000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
184000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
184000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
2817000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
3672000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
352000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
454000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-500000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
853000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-369000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-133000 USD
CY2012Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
237000 USD
CY2013Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
252000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-130000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-41000 USD
CY2012Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-229000 USD
CY2013Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-197000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
101000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
89000 USD
CY2013Q1 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
290000 USD
CY2012Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
518000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
584000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1861000 USD
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2297000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
7544000 USD
CY2013Q1 us-gaap Inventory Gross
InventoryGross
7770000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
4979000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
4868000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2522000 USD
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2690000 USD
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2902000 USD
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
26000 USD
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
22000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2565000 USD
CY2013Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2783000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3161000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
8460000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
8625000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44909000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42744000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8284000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8368000 USD
CY2013Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
385000 USD
CY2012Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
385000 USD
CY2013Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Digirad Corporation (&#8220;Digirad"), a Delaware corporation, is one of the largest national providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers through our Digirad Imaging Solutions (&#8220;DIS&#8221;) segment. Through DIS, we provide in-office imaging services to physicians, offering certified personnel, required licensure, an imaging system and other support and supplies for the performance of nuclear and ultrasound imaging procedures under the supervision of our physician customers. DIS' physician customers enter into service contracts for imaging services generally delivered on a per-day basis. We also sell medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provide service on the products we sell through our Diagnostic Imaging segment. These </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, DIS and Diagnostic Imaging, are collectively referred to herein as the &#8220;Company&#8221;. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements include the operations of both segments. Intercompany accounts and transactions are accounted for at cost and have been eliminated in consolidation. All our long-lived assets are located in the United States and substantially all of our revenues arise from sales activity in the United States. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included in this Form 10-Q have been prepared in accordance with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) instructions for Quarterly Reports on Form 10-Q. Accordingly, the condensed consolidated financial statements are unaudited and do not contain all the information required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) to be included in a full set of financial statements. The unaudited condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;"> has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for a complete set of financial statements. The audited consolidated financial statements for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on Form 10-K on March 13, 2013 include a summary of our significant accounting policies and should be read in conjunction with this Form 10-Q. In the opinion of management, all material adjustments necessary to present fairly the results of operations, cash flows and balance sheets for such periods have been included in this Form 10-Q. All such adjustments are of a normal recurring nature. The results of operations for interim periods are not necessarily indicative of the results of operations for the entire year.</font></div></div>
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
896000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2818000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1065000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1169000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-2419000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-1268000 USD
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10000 USD
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
4954000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
5226000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1282000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2409000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2199000 USD
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2130000 USD
CY2013Q1 us-gaap Other Assets Current
OtherAssetsCurrent
792000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
703000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-40000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-40000 USD
CY2013Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4679000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
176000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
257000 USD
CY2012Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-12000 USD
CY2013Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-32000 USD
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20000 USD
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
118000 USD
CY2012Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
189000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
187000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34000 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2050000 USD
CY2012Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1059000 USD
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
24000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2013Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
244000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
326000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25994000 USD
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26173000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4693000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4557000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
897000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
818000 USD
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
244000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
244000 USD
CY2012Q1 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
1004000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
714000 USD
CY2013Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
714000 USD
CY2013Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
1004000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118118000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120537000 USD
CY2013Q1 us-gaap Revenues
Revenues
11546000 USD
CY2012Q1 us-gaap Revenues
Revenues
12969000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3680000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2607000 USD
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9289000 USD
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
8939000 USD
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19242000 shares
CY2013Q1 digirad Other Accrued Restructuring Charges
OtherAccruedRestructuringCharges
64000 USD
CY2012Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1715000 USD
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1236000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
189000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
121000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
12000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
7000000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
36449000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
34119000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1073641 shares
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1081641 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2086000 USD
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2106000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1500000 USD
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19322000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19242000 shares
CY2013Q1 digirad Restructuring And Related Cost Expected Cost Employee Related
RestructuringAndRelatedCostExpectedCostEmployeeRelated
1700000 USD
CY2013Q1 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2012Q1 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1200000 USD
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19242000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19322000 shares
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19322000 shares
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000707388
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19243079 shares
CY2013Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
DIGIRAD CORP
CY2013Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0000707388-13-000014-index-headers.html Edgar Link pending
0000707388-13-000014-index.html Edgar Link pending
0000707388-13-000014.txt Edgar Link pending
0000707388-13-000014-xbrl.zip Edgar Link pending
digirad-20130331.xml Edgar Link completed
digirad-20130331.xsd Edgar Link pending
digirad-20130331_cal.xml Edgar Link unprocessable
digirad-20130331_def.xml Edgar Link unprocessable
digirad-20130331_lab.xml Edgar Link unprocessable
digirad-20130331_pre.xml Edgar Link unprocessable
drad-3312013x10q.htm Edgar Link pending
drad-3312013xex3116.htm Edgar Link pending
drad-3312013xex3126.htm Edgar Link pending
drad-3312013xex3216.htm Edgar Link pending
drad-3312013xex3226.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending